By joining this group you will also get the opportunity to subscribe to its activity.
Join this group
Articles
Colorectal Therapies Healthcare Technology Co-operative: The Nanotechnology Theme
Dr Kevin Critchley of the HTC Colorectal Therapies & Leeds University, will present on 'Colorectal Therapies Healthcare Technology Co-operative: The Nanotechnology Theme' at Nano4Life...
Business Intelligence for Nanomedicines
NanoScientium will present on 'Business Intelligence for Nanomedicines' at Nano4Life 2014 taking place this week in London.
The global nanomedicine market is anticipated to grow to...
Nanotechnology in the Pharmaceutical Industry
Nano4Life 2014: Convering Nanotechnology with the Life Science Industry
5th March 2014, Royal Academy of Engineering, London
...
What is Nanomedicine - its Impact on Healthcare
Prof Mike Eaton, Vice Chair Working Group, Nanotherapeutics at the Nanomedicine European Technology Platform, will present the keynote on 'What is Nanomedicine - its Impact on Healthcare' at ...
Nanocin(Tm), a Flexible & Safe Cell Delivery Platform: A Novel Nanomedicine?
Dr Liam Good, Director at Tacrea Ltd, will present on 'Nanocin(Tm), a Flexible & Safe Cell Delivery Platform: A Novel Nanomedicine?' at Nano4Life2014 taking place on 5th March 2014 in...
NanoKTN Sparks New Nanomedicine Intelligence Start-Up: NanoScientium
New Company, NanoScientium, to offer business intelligence services for nanomedicine and medical devices markets.
The NanoKTN is pleased to announce the foundation of a new start-up...
Novartis sneaking up on Pfizer for pharma's top spot
Pfizer has remained the world’s largest public manufacturer of pharmaceuticals, according to an industry report, though dropped revenue in 2012 has left Novartis hot on its heels .
Last...
NanoKTN Helps Drug Discovery Solution Provider Pharmidex Find New Facility
Stevenage Bioscience Catalyst, the UK’s First Open Innovation (OI) Bioscience Campus, is New Home for Pharmidex.
The NanoKTN is pleased to announce that it has helped one of its members...
Pharmaceutical Nanotechnology Congregation 2013
“A lifeline for drying pharma pipelines”
15th & 16th October 2013, Marriott Hotel Maida Vale, London, UK
For more info on the event and for event brochure click here .
KEY...
Crowdfunding Campaign for Nanotech Cancer Treatment
Two researchers from the University of York are utilising the crowdfunding platform - Microryza - to raise funds to research a nanoparticle cancer treatment. The two are looking to raise $3000...
Forthcoming Funding Call: Innovation in Drug Development Processes
The Centre for Defence Enterprise (CDE) is launching an SBRI competition on behalf of the MOD Defence Science and Technology Laboratory (Dstl).
The purpose of this CDE themed...
Nanotechnology in the Pharmaceutical Industry
The Nanotechnology in the Pharmaceutical Industry session at Wednesday's Nano4Life 2013 in London will feature three speakers:
Keynote: Nanomedicine(s) -...
Using Nanomedicines to Improve Therapeutic Index of Drugs
Dr Marianne Ashford, Principal Scientist at AstraZeneca will present on 'Using Nanomedicines to Improve Therapeutic Index of Drugs' at Nano4Life 2013 taking place in London on 15th...
BIND Therapeutics Announce Worldwide Development and Commercialization Agreement for Cancer Nanomedicine
BIND Therapeutics and AstraZeneca announced yesterday that they have entered into a strategic collaboration to develop and commercialize an Accurin™, based on a molecularly targeted kinase...
Formulated Products - Competition Briefing & Consortium Building
Following the announcement of the collaborative R&D and feasility competitions from TSB on Formulated Products ; please be aware that on May 1st a competition briefing event is being...
Challenges and Opportunities for the Development of Long-Acting Antiretrovirals: the View of the Clinician
Dr Marta Boffito, Consultant Physician at the Chelsea and Westminster Hospital & Clinical Lead in Clinical Trials for the St. Stephen’s AIDS Trust, will present on ...
Nanomerics win UKTI competition to attend BIO 2013
Nanomerics was one of 4 UK Life Science companies to win a recent UKTI Innovation Competition, which will enable them to showcase their technologies to an international audience at the upcoming...
BIND Therapeutics Announces Global Collaboration with Pfizer
BIND Therapeutics, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called Accurins™, announced today that it...
Formulated Products - TSB Collaborative R&D funding competition
The formulated products market in the UK is worth around £180bn a year. This competition is designed to support innovative developments which overcome the challenges facing the formulated...
Forthcoming TSB collaborative R&D competition in Formulation
Technology Strategy Board will be providing up to £5M to co-fund industry-led innovation projects in the area of formulation, the call document will be available in March 2013. There will...
Click here to view news articles on funding opportunities in this area, and more general funding opportunities.